PA
Perceptive Advisors’s Allogene Therapeutics ALLO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-2,725,000
| Closed | -$7.63M | – | 99 |
|
2024
Q3 | $7.63M | Hold |
2,725,000
| – | – | 0.16% | 74 |
|
2024
Q2 | $6.35M | Buy |
+2,725,000
| New | +$6.35M | 0.15% | 73 |
|
2021
Q2 | – | Sell |
-1,143,790
| Closed | -$40.4M | – | 150 |
|
2021
Q1 | $40.4M | Hold |
1,143,790
| – | – | 0.51% | 48 |
|
2020
Q4 | $28.9M | Hold |
1,143,790
| – | – | 0.31% | 65 |
|
2020
Q3 | $43.1M | Sell |
1,143,790
-400,000
| -26% | -$15.1M | 0.63% | 41 |
|
2020
Q2 | $66.1M | Hold |
1,543,790
| – | – | 1.07% | 24 |
|
2020
Q1 | $30M | Hold |
1,543,790
| – | – | 0.78% | 32 |
|
2019
Q4 | $40.1M | Hold |
1,543,790
| – | – | 0.8% | 32 |
|
2019
Q3 | $42.1M | Hold |
1,543,790
| – | – | 1.13% | 25 |
|
2019
Q2 | $41.5M | Hold |
1,543,790
| – | – | 0.95% | 27 |
|
2019
Q1 | $44.6M | Hold |
1,543,790
| – | – | 1.26% | 23 |
|
2018
Q4 | $41.6M | Buy |
+1,543,790
| New | +$41.6M | 1.58% | 19 |
|